Profile
| Metric | Value |
|---|---|
| Full Name | CME Group Inc. |
| Ticker | NASDAQ: CME |
| Exchange | NASDAQ |
| Sector | Financial Services |
| Industry | Financial Data & Stock Exchanges |
| Country | United States |
| IPO | |
| Indexes | |
| Website | cmegroup.com |
| Employees | 3,760 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $264.98 | |
| Price, 1D Change | +0.96% | |
| Market Cap | $96B | |
| TTM Dividend Yield | 1.89% | |
| PE Ratio | 25.69 | |
| Beta | -0.07 | |
| Revenue | $6B | |
| Revenue, 1Y Change | +9.88% | |
| EPS | $9.67 | |
| EPS, 1Y Change | +9.15% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.25 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 5:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $9.67 | |
| EPS Estimate | $11.17 | |
| EPS Est. Change | +15.44% | |
| Revenue | $6.13B | |
| Revenue Estimate | $6.52B | |
| Revenue Est. Change | +6.36% | |
| Current Price | $264.98 | |
| Price Target | - | $300.00 |
| Price Tgt. Change | - | +13.22% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.25 | $8.86 | -4.20% | |
| $10.19 | $9.67 | -5.07% | |
| $11.17 | N/A | +15.44% | |
| $11.65 | N/A | +20.49% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.56B | $5.58B | +0.30% | |
| $6.10B | $6.13B | +0.46% | |
| $6.52B | N/A | +6.36% | |
| $6.82B | N/A | +11.23% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +15.61% | |
| Price, 3Y | +49.95% | |
| Market Cap, 1Y | +15.93% | |
| Market Cap, 3Y | +50.65% | |
| Revenue, 1Y | +9.88% | |
| Revenue, 3Y | +30.71% | |
| EPS, 1Y | +9.15% | |
| EPS, 3Y | +32.65% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $264.98 | |
| SMA 200 | $271.65 | |
| SMA 200 vs Price | +2.52% | |
| SMA 50 | $273.21 | |
| SMA 50 vs Price | +3.11% | |
| Beta | -0.07 | |
| ATR | $5.27 | |
| 14-Day RSI | 41.29 | |
| 10-Day Volatility | 20.27% | |
| 1-Year Volatility | 18.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.25 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 3.92% | |
| Total Dividend | $10.40 | |
| Dividends Paid | $3.58B | |
| Payout Ratio | 101.56% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $6.13B | |
| EPS | $9.67 | |
| Gross Profit | $5.05B | |
| Gross Margin | 82.37% | |
| Operating Profit | $3.93B | |
| Operating Margin | 64.13% | |
| Net Income | $3.53B | |
| Net Margin | 57.57% | |
| EBITDA | $4.27B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.14 | |
| Current Ratio | 1.01 | |
| Quick Ratio | 1.01 | |
| Interest Coverage | 24.43 | |
| F-Score | 4 | |
| Altman Z-Score | 0.70 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 25.69 | |
| PS Ratio | 14.94 | |
| PB Ratio | 3.39 | |
| EV/EBITDA | 21.55 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $26.49B | |
| Cash & Equivalents | $3.01B | |
| Total Assets | $137.59B | |
| Current Assets | $103.03B | |
| Total Liabilities | $111.10B | |
| Current Liabilities | $102.31B | |
| Total Debt | $3.82B | |
| Short Term Debt | $803.20M | |
| Accounts Payable | $79.90M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $2.60B | |
| Operating Expenses | $1.12B | |
| Cost Of Goods Sold | $1.08B | |
| SG&A | $0.00 | |
| D&A | $336.80M | |
| Interest Expense | $160.90M | |
| Income Tax | $1.02B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $3.69B | |
| CFI | -$82.60M | |
| CFF | $5.08B | |
| Capex | $94.00M | |
| Free Cash Flow | $3.60B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Morgan Stanley | → | |
| Barclays | → | |
| Piper Sandler | → | |
| UBS | → | |
| Morgan Stanley | → | |
| Deutsche Bank | → | |
| Raymond James | → | |
| Barclays | → | |
| Morgan Stanley | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with CME
Data Sources & References
- CME Official Website www.cmegroup.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- CME Profile on Yahoo Finance finance.yahoo.com/quote/CME
- CME Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cme
FAQ
What is the ticker symbol for CME Group Inc.?
The ticker symbol for CME Group Inc. is NASDAQ:CME
Does CME Group Inc. pay dividends?
Yes, CME Group Inc. pays dividends. The last payment was $1.25, with an ex-dividend date on December 12, 2025
What sector is CME Group Inc. in?
CME Group Inc. is in the Financial Services sector
What industry is CME Group Inc. in?
CME Group Inc. is in the Financial Data & Stock Exchanges industry
What country is CME Group Inc. based in?
CME Group Inc. is headquartered in United States
When did CME Group Inc. go public?
CME Group Inc. initial public offering (IPO) was on December 6, 2002
Is CME Group Inc. in the S&P 500?
Yes, CME Group Inc. is included in the S&P 500 index
Is CME Group Inc. in the NASDAQ 100?
No, CME Group Inc. is not included in the NASDAQ 100 index
Is CME Group Inc. in the Dow Jones?
No, CME Group Inc. is not included in the Dow Jones index
When was CME Group Inc. last earnings report?
CME Group Inc.'s most recent earnings report was on October 22, 2025
When does CME Group Inc. report earnings?
The next expected earnings date for CME Group Inc. is February 4, 2026
